๐ฐ Cr News
Page 427 - Cr News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cr. Real-time updates on events, politics, business and more.
March 25, 2022
Independent PR firms enjoyed robust growth in 2021 as fee income surged 29.7 percent.
March 25, 2022
Ahead of Sunday’s Oscar ceremony, the Academy of Motion Pictures Arts and Sciences...
March 25, 2022
The new guideline will go into effect on March 29
March 23, 2022
In a very tragic incident, 11 people were charred to death due to the major fire accident at a scrap godown in Bhoiguda, Secunderabad. The fire incident took place in the morning around 4 am. A team of firefighters arrived immediately and doused the fire.ย Short Circuit could be the reason for the fire. All deceased wereย migrant workers from Bihar. Telangana Chief Minister K
March 23, 2022
JOHANNESBURG (AP) โ With declining cases of COVID-19, South Africas president has...
March 23, 2022
The relaxation of the COVID-19 restrictions has nothing to do with a change in the disease, its seriousness, or its spread. As numbers out of China, Europe, and elsewhere clearly
March 22, 2022
The new testing strategy is designed to allow the city to target specific neighborhoods...
March 22, 2022
Chemveda Life Sciences now will invest an additional INR 150 crores (USD 20 Million) to add a state-of-the-art R&D center in Hyderabad with around 200,000 sqft, creating additional employment for 500 scientists. They have already received a funding of INR 90 crores (USD 12 mn) and another INR 60 crores (USD 8 mn) is committed funding.
March 22, 2022
Telangana Next Cm 2023: Prashant Kishor Working With TRS For Free! Telangana Chief Minister and TRS party president K Chandrashekar Rao made it clear that they are not going for early polls as they did in the 2018 Assembly Polls. He expressed hope that TRS Party is going to get 95 to 105 seats in the next polls. He further stated that he was taking the help of poll strategist
March 22, 2022
Affini-T Therapeutics is developing new cell therapies for cancer that could overcome limitations of the first generation of cell therapies. The initial genomic cancer targets of the startup are mutations of KRAS and p53, both of which have proven difficult to drug.